drugset / Trial / NCT00043927
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy. One treatment will use an investigational drug in combination with an FDA approved chemotherapy. The other treatment will use a combination of two FDA approved chemotherapy drugs.
Timeline
- Start
- 2001-04
- Primary completion
- 2004-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etoposide | Small molecule | — | — |
| Subject | Topotecan | Small molecule | — | Oral |
| Background | Cisplatin | Other / unclassified | — | — |